TEVA

Teva Pharmaceutical Industries Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 9/10
  • Value↓ 3/10
Teva Pharmaceutical Industries sales and earnings growth
TEVA Growth
Great
  • Revenue Y/Y↓ 2.96%
  • EPS Y/Y↑ 220.18%
  • FCF Y/Y↑ 53.20%
Teva Pharmaceutical Industries gross and profit margin trends
TEVA Profitability
Neutral
  • Gross margin ↑ 52.10%
  • EPS margin↓ 9.00%
  • ROIC 5Y↓ 3.13%
Teva Pharmaceutical Industries net debt vs free cash flow
TEVA Risk
Fair
  • Debt / Equity↑ 2.1
  • Debt / FCF↑ 11.2
  • Interest coverage↓ 2.5

Teva Pharmaceutical Industries stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks